Ibuprofen may decrease the excretion rate of Neomycin which could result in a higher serum level. Ibuprofen may decrease the antihypertensive activities of Timolol. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Higenamine. The metabolism of Ibuprofen can be decreased when combined with Lobeglitazone. The metabolism of Ibuprofen can be increased when combined with Rifapentine. The metabolism of Ibuprofen can be decreased when combined with Ticagrelor. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Desonide. The therapeutic efficacy of Metolazone can be decreased when used in combination with Ibuprofen. The therapeutic efficacy of Folic Acid can be decreased when used in combination with Ibuprofen. Ibuprofen may decrease the excretion rate of Apramycin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Pirfenidone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Prasterone. Ibuprofen may decrease the excretion rate of Amikacin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tixocortol. The risk or severity of adverse effects can be increased when Masoprocol is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Benoxaprofen. The risk or severity of adverse effects can be increased when Trandolapril is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Epirizole. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Equilin. The therapeutic efficacy of Sulprostone can be decreased when used in combination with Ibuprofen. Ibuprofen may increase the neuroexcitatory activities of Rosoxacin. The metabolism of Ibuprofen can be increased when combined with Primidone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with E-6201. The metabolism of Ibuprofen can be decreased when combined with Fluoxetine. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Andrographolide. Ibuprofen may increase the anticoagulant activities of Letaxaban. Ibuprofen may decrease the excretion rate of Zoptarelin doxorubicin which could result in a higher serum level. Ibuprofen may increase the anticoagulant activities of Reviparin. The risk or severity of adverse effects can be increased when Salicylic acid is combined with Ibuprofen. The metabolism of Ibuprofen can be decreased when combined with Clotrimazole. Ibuprofen may decrease the excretion rate of GENTAMICIN C1A which could result in a higher serum level. Ibuprofen may decrease the excretion rate of Spectinomycin which could result in a higher serum level. Ibuprofen may increase the anticoagulant activities of Ethyl biscoumacetate. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Salsalate. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Estrone sulfate. Ibuprofen may decrease the antihypertensive activities of Metipranolol. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Beclomethasone dipropionate. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Rimexolone. The risk or severity of adverse effects can be increased when Tenoxicam is combined with Ibuprofen. The metabolism of Ibuprofen can be increased when combined with Phenytoin. The risk or severity of adverse effects can be increased when Fimasartan is combined with Ibuprofen. Ibuprofen may decrease the antihypertensive activities of Alprenolol. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Nimesulide. Sodium phosphate may increase the nephrotoxic activities of Ibuprofen. Ibuprofen may increase the hyperkalemic activities of Drospirenone. The metabolism of Ibuprofen can be decreased when combined with Indinavir. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Deflazacort. Ibuprofen may decrease the excretion rate of Plicamycin which could result in a higher serum level. The metabolism of Ibuprofen can be decreased when combined with Quinine. The metabolism of Ibuprofen can be decreased when combined with Valproic Acid. Ibuprofen may increase the anticoagulant activities of Lepirudin. The serum concentration of Ibuprofen can be increased when it is combined with Ceritinib. The risk or severity of adverse effects can be increased when Candoxatril is combined with Ibuprofen. The metabolism of Ibuprofen can be increased when combined with Aprepitant. The risk or severity of adverse effects can be increased when Temocapril is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Naproxen is combined with Ibuprofen. Ibuprofen may decrease the antihypertensive activities of Triamterene. The metabolism of Ibuprofen can be decreased when combined with Sulfamethoxazole. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Prednisone. Ibuprofen may increase the anticoagulant activities of Gabexate. Ibuprofen may decrease the diuretic activities of Etacrynic acid. The metabolism of Ibuprofen can be decreased when combined with Eslicarbazepine acetate. Cholestyramine can cause a decrease in the absorption of Ibuprofen resulting in a reduced serum concentration and potentially a decrease in efficacy. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Prasterone sulfate. The serum concentration of Pralatrexate can be increased when it is combined with Ibuprofen. Ibuprofen may increase the anticoagulant activities of Abciximab. The risk or severity of adverse effects can be increased when Zofenopril is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with SRT501. Ibuprofen may decrease the antihypertensive activities of Penbutolol. The risk or severity of adverse effects can be increased when Morniflumate is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Oxyphenbutazone. Ibuprofen may increase the neuroexcitatory activities of Enoxacin. Ibuprofen may increase the anticoagulant activities of Argatroban. The metabolism of Ibuprofen can be decreased when combined with Nilotinib. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Serrapeptase. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alclometasone. Ibuprofen may decrease the antihypertensive activities of Celiprolol. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Anecortave. The risk or severity of adverse effects can be increased when Ibuprofen is combined with 5-androstenedione. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Loteprednol. Ibuprofen may decrease the antihypertensive activities of Hydralazine. Ibuprofen may decrease the diuretic activities of Piretanide. Ibuprofen may decrease the excretion rate of Tobramycin which could result in a higher serum level. The metabolism of Ibuprofen can be decreased when combined with Pyrimethamine. The risk or severity of adverse effects can be increased when Etanercept is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Zileuton is combined with Ibuprofen. Ibuprofen may decrease the excretion rate of Aclarubicin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tinoridine. The serum concentration of Imatinib can be decreased when it is combined with Ibuprofen. Ibuprofen may decrease the excretion rate of Gentamicin which could result in a higher serum level. Ibuprofen may increase the anticoagulant activities of Sulodexide. The risk or severity of adverse effects can be increased when Enalapril is combined with Ibuprofen. Ibuprofen may decrease the antihypertensive activities of Befunolol. The risk or severity of adverse effects can be increased when Lisinopril is combined with Ibuprofen. Ibuprofen may decrease the antihypertensive activities of Sotalol. The risk or severity of adverse effects can be increased when Saprisartan is combined with Ibuprofen. The therapeutic efficacy of Dinoprost Tromethamine can be decreased when used in combination with Ibuprofen. The therapeutic efficacy of Beraprost can be decreased when used in combination with Ibuprofen. The metabolism of Ibuprofen can be increased when combined with Rifampicin. Colesevelam can cause a decrease in the absorption of Ibuprofen resulting in a reduced serum concentration and potentially a decrease in efficacy. The metabolism of Ibuprofen can be decreased when combined with Bortezomib. The risk or severity of adverse effects can be increased when Rescinnamine is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Ibuproxam. The risk or severity of adverse effects can be increased when Sacubitril is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Aceclofenac. The serum concentration of Ibuprofen can be increased when it is combined with Luliconazole. Ibuprofen may increase the neuroexcitatory activities of Pazufloxacin. The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Ibuprofen. The serum concentration of Digoxin can be increased when it is combined with Ibuprofen. Ibuprofen may increase the anticoagulant activities of Certoparin. The metabolism of Ibuprofen can be decreased when combined with Teriflunomide. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Desoxycorticosterone Pivalate. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Apocynin. The metabolism of Ibuprofen can be decreased when combined with Fluvastatin. Ibuprofen may decrease the excretion rate of Neamine which could result in a higher serum level. Ibuprofen may decrease the antihypertensive activities of Nebivolol. The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Ibuprofen. The therapeutic efficacy of Latanoprost can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Medrysone. The metabolism of Ibuprofen can be decreased when combined with Tolbutamide. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Cortexolone 17α-propionate. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Duvelisib. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Etoricoxib. The metabolism of Ibuprofen can be decreased when combined with Losartan. Ibuprofen may increase the anticoagulant activities of Phenindione. Ibuprofen may decrease the antihypertensive activities of Acebutolol. The risk or severity of adverse effects can be increased when Carprofen is combined with Ibuprofen.